{"slideshow_credits": null, "snippet": "In a highly unusual move, the agency has decided to reopen the case on Avandia and will ask a committee whether it should reconsider the restrictions on the drug.", "abstract": "Food and Drug Administration decides to reopen case on diabetes drug Avandia and ask panel of experts whether it must reconsider restrictions on drug; Avandia was all but banned from use three years ago after researchers found thousands of people had heart problems after taking it; lifting limits would amount to major policy reversal and huge victory for GlaxoSmithKline.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}, {"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 2, "organization": ""}], "original": "By KATIE THOMAS and SABRINA TAVERNISE", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/03/business/second-thoughts-on-safety-of-avandia-stir-a-dispute.html", "lead_paragraph": "In a highly unusual move, the agency has decided to reopen the case on Avandia and will ask a committee whether it should reconsider the restrictions on the drug.", "headline": {"seo": "Second Thoughts on Safety of Avandia Stir a Dispute", "main": "F.D.A. to Reconsider Restrictions on Diabetes Drug", "print_headline": "A Dispute Over Safety Of a Drug For Diabetes"}, "_id": "51aba00340e9ec65d203ad6b", "word_count": "1429", "multimedia": [{"height": 126, "url": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 860, "url": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "860"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/03/business/0603AVANDIA/0603AVANDIA-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Avandia (Drug)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Diabetes", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Heart", "name": "subject", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}